A Multiple-Dose Clinical Trial to Study the Effect of MK-8457 on Ambulatory Blood Pressure in Hypertensive Patients.
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2017
At a glance
- Drugs MK 8457 (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 03 Apr 2012 Actual patient number 31 added as reported by ClinicalTrials.gov.
- 03 Apr 2012 Status changed from active, no longer recruiting to completed.
- 24 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.